161 related articles for article (PubMed ID: 21277009)
1. Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancer.
Song YJ; Lim MC; Kang S; Seo SS; Kim SH; Han SS; Park SY
Gynecol Oncol; 2011 May; 121(2):253-7. PubMed ID: 21277009
[TBL] [Abstract][Full Text] [Related]
2. Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Martinez A; Pomel C; Mery E; Querleu D; Gladieff L; Ferron G
Gynecol Oncol; 2011 May; 121(2):258-63. PubMed ID: 21295334
[TBL] [Abstract][Full Text] [Related]
3. Porta hepatis peritonectomy and hepato-celiac lymphadenectomy in patients with stage IIIC-IV ovarian cancer: Diagnostic pathway, surgical technique and outcomes.
Tozzi R; Traill Z; Garruto Campanile R; Ferrari F; Soleymani Majd H; Nieuwstad J; Hardern K; Gubbala K
Gynecol Oncol; 2016 Oct; 143(1):35-39. PubMed ID: 27519966
[TBL] [Abstract][Full Text] [Related]
4. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
5. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer.
Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N
Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370
[TBL] [Abstract][Full Text] [Related]
6. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
7. Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer.
Gasparri ML; Grandi G; Bolla D; Gloor B; Imboden S; Panici PB; Mueller MD; Papadia A
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1509-20. PubMed ID: 26660323
[TBL] [Abstract][Full Text] [Related]
8. Complete tumor resection and demonstration of detailed anatomy of the porta hepatis in a patient with recurrent epithelial ovarian cancer.
Taskiran C; Vatansever D; Misirlioglu S; Giray B; Kumcular T; Arvas M; Erkan M
Int J Gynecol Cancer; 2021 Jan; 31(1):148-149. PubMed ID: 33303569
[No Abstract] [Full Text] [Related]
9. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
[TBL] [Abstract][Full Text] [Related]
10. Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation.
Nasser S; Lazaridis A; Evangelou M; Jones B; Nixon K; Kyrgiou M; Gabra H; Rockall A; Fotopoulou C
Gynecol Oncol; 2016 Nov; 143(2):264-269. PubMed ID: 27586894
[TBL] [Abstract][Full Text] [Related]
11. [Significance of hepatic resection in the treatment of hepatic parenchymal metastasis of recurrent epithelial ovarian carcinoma].
Yan X; Bao Q; An N; Gao YN; Jiang GQ; Gao M; Zheng H; Wang W
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):132-7. PubMed ID: 21575484
[TBL] [Abstract][Full Text] [Related]
12. Hepatic resection for metachronous metastases from ovarian carcinoma.
Merideth MA; Cliby WA; Keeney GL; Lesnick TG; Nagorney DM; Podratz KC
Gynecol Oncol; 2003 Apr; 89(1):16-21. PubMed ID: 12694649
[TBL] [Abstract][Full Text] [Related]
13. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
[TBL] [Abstract][Full Text] [Related]
14. Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.
Minaguchi T; Satoh T; Matsumoto K; Sakurai M; Ochi H; Onuki M; Oki A; Yoshikawa H
Int J Clin Oncol; 2016 Jun; 21(3):573-9. PubMed ID: 26475355
[TBL] [Abstract][Full Text] [Related]
15. Traumatic injuries to the porta hepatis: case report and review of the literature.
Theunis P; Coenen L; Brouwers J
Injury; 1989 May; 20(3):152-6. PubMed ID: 2689342
[TBL] [Abstract][Full Text] [Related]
16. Preoperative factors predicting survival after secondary cytoreduction for recurrent ovarian cancer.
Frederick PJ; Ramirez PT; McQuinn L; Milam MR; Weber DM; Coleman RL; Gershenson DM; Landen CN
Int J Gynecol Cancer; 2011 Jul; 21(5):831-6. PubMed ID: 21613957
[TBL] [Abstract][Full Text] [Related]
17. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413
[TBL] [Abstract][Full Text] [Related]
18. The Role of Quaternary Cytoreduction in Recurrent Epithelial Ovarian Cancer: A Single-center Experience.
Bacalbaşa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Jun; 35(6):3519-23. PubMed ID: 26026119
[TBL] [Abstract][Full Text] [Related]
19. Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective study.
Falcone F; Scambia G; Benedetti Panici P; Signorelli M; Cormio G; Giorda G; Bogliolo S; Marinaccio M; Ghezzi F; Rabaiotti E; Breda E; Casella G; Fanfani F; Di Donato V; Leone Roberti Maggiore U; Greggi S
Gynecol Oncol; 2017 Oct; 147(1):66-72. PubMed ID: 28716306
[TBL] [Abstract][Full Text] [Related]
20. Secondary cytoreductive surgery in recurrent epithelial ovarian cancer: A prognostic analysis with 103 cases.
Fan XM; Zhang J; Niu SH; Li KX; Song CZ
Int J Surg; 2017 Feb; 38():61-66. PubMed ID: 28027999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]